Citation Tools

Download PDFPDF
CP-098 Economic impact of implementation of natalizumab use with extended interval dosing in patients with relapsing remitting multiple sclerosis

Download to a citation manager

Cite this article as:
Moya-Carmona I, Dominguez-Rivas Y, Pedrosa-Ruiz M, et al
CP-098 Economic impact of implementation of natalizumab use with extended interval dosing in patients with relapsing remitting multiple sclerosis